Articles tagged "Infection"

2021 American Transplant Congress
SARS-CoV-2 Infection Among Kidney Transplant Recipients: A Multicenter Brazilian Cohort Study
T. Sandes-Freitas¹, J. Medina-Pestana², o. COVID-19 Brazil Study Group³
¹Universidade Federal do Ceará, Fortaleza, Brazil, ²Hospital do Rim, São Paulo, Brazil, ³Brazil, Brazil, Brazil
*Purpose: Limited data are available on COVID-19 clinical presentation and outcomes among kidney transplant (KT) recipients.*Methods: Multicenter Brazilian cohort of KT patients with laboratory-confirmed SARS-CoV-2…
2021 American Transplant Congress
Criteria and Practice Patterns for Accepting Living Donors with Prior Covid-19: A National Survey
A. Jawed¹, M. Y. Jan², N. Barros², O. Adebiyi², A. Diez³, J. Fridell², W. Goggins², M. Yaqub², M. A. Mujtaba⁴, T. Taber², V. Kumar⁵, K. Lentine⁶, A. Sharfuddin²
¹Wayne State University, Detroit, IN, ²Indiana University School of Medicine, Indianapolis, IN, ³The Ohio State University, Columbus, OH, ⁴UTMB Galveston, Galveston, TX, ⁵University of Alabama, Birmingham, AL, ⁶St. Louis University, St. Louis, MO
*Purpose: A critical question facing transplant programs is if, when and how to safely accept living kidney donors (LKD) who have a history and recovered…
2021 American Transplant Congress
COVID-19 Presentation and Severity Within One Year of Pancreas and Kidney Transplantation
H. Sarumi, J. Fisher, B. Johnson, T. Pruett
University of Minnesota, Minneapolis, MN
*Purpose: The current pandemic has created uncertainty of induction regimen impact upon severity of COVID-19 disease. Our experience with COVID-19 infection was reviewed to stratify…
2021 American Transplant Congress
Profile of SARS-CoV-2 Antibodies in Patients Awaiting Kidney Transplantation
L. Muir¹, A. Jaffer², C. Rees-Spear¹, V. Gopalan², F. Chang², G. Vaitkute¹, R. Fernando³, C. Roustan⁴, A. Rosa⁴, C. Earl⁴, A. Salama², P. Cherepanov⁴, L. E. McCoy¹, R. Motallebzadeh²
¹Institute of Immunity & Transplantation, University College London, London, United Kingdom, ²Nephrology & Transplantation, Royal Free London Hospital NHS Trust, London, United Kingdom, ³Anthony Nolan Institute, Royal Free London Hospital NHS Trust, London, United Kingdom, ⁴The Francis Crick Institute, London, United Kingdom
*Purpose: Patients with end-stage kidney disease (ESKD) represent an extremely vulnerable group with many risk factors for adverse outcomes following SARS-CoV-2 infection. Key questions pertaining…
2021 American Transplant Congress
Impact of a Pharmacist-driven Immunization Clinic on Vaccination Rates in Pre-liver Transplant Patients
A. Poparad-Stezar¹, B. Summers¹, M. Fitzmaurice¹, K. Hakamiun², N. Sulejmani³, A. Jantz¹
¹Henry Ford Hospital, Detroit, MI, ²Select Medical, Wyandotte, MI, ³CareDx, Inc., Sterling Heights, MI
*Purpose: Infectious diseases are a leading cause of morbidity and mortality among patients with end-stage liver disease (ESLD). Vaccination data of ESLD patients pre- and…
2021 American Transplant Congress
Clinical Outcomes of Solid Organ Transplant Recipients with Severe Acute Respiratory Syndrome Coronavirus 2
R. Adekunle, D. Jandhyala, J. Lewis
Medicine, Division of Infectious Diseases, Medical University of South Carolina, Charleston, SC
*Purpose: The Centers for Disease Control and Prevention identified solid organ transplant (SOT) recipients as persons at high risk to develop severe illness secondary to…
2021 American Transplant Congress
The Gut Microbiota Diversity and Metabolite Production is Reduced in Liver Transplant Recipients and Associated with Post-Operative Infection
C. J. Lehmann, R. Keskey, R. Nayak, E. Littmann, E. Pamer, T. Baker
University of Chicago, Chicago, IL
*Purpose: Liver transplant (LT) recipients have abnormal microbiota before and after transplantation. (1,2) The association between fecal microbiota, metabolites, and clinical outcomes in liver transplantation…
2021 American Transplant Congress
Ganciclovir Therapeutic Drug Monitoring in Obese Adults Patients – Opportunity for Clinical Utility
Y. Tran¹, S. Bernard¹, R. W. Stevens¹, L. Myhre¹, R. Razonable²
¹Department of Pharmacy, Mayo Clinic, Rochester, MN, ²Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, MN
*Purpose: Ganciclovir (GCV) is the drug of choice for the treatment of cytomegalovirus (CMV) infection; optimal dosing of GCV in the obese patient population is…
2021 American Transplant Congress
Risk Factors Associated with Multidrug Resistant Organism (MDRO) Infections in Kidney Transplant Recipients: A Single Center Experience
S. Schrank¹, J. Timpone², B. Javaid³, P. Kumar², M. Cooper³
¹Internal Medicine, MedStar Georgetown University Hospital, Washington, DC, ²Infectious Diseases and Travel Medicine, MedStar Georgetown University Hospital, Washington, DC, ³Transplant Institute, MedStar Georgetown University Hospital, Washington, DC
*Purpose: Risk factors for MDRO infections in kidney transplant recipients have previously been studied but limited to urinary tract infections. We sought to evaluate the…
2021 American Transplant Congress
Longitudinal Studies of Blood Donor-derived Cell Free DNA (dd-cfDNA) Show Predictable Rise at Time of BK Viremia or Viruria in Pediatric Kidney Transplant Recipients (PKTx)
R. Dandamudi¹, H. Gu¹, C. Goss¹, S. Federman², R. Woodward², S. Dholakia², L. Walther¹, V. Dharnidharka¹
¹Washington University in St Louis, St. Louis, MO, ²CareDx, Brisbane, CA
*Purpose: Blood levels of dd-cfDNA elevate in various forms of kidney transplant injury, most notably used for detecting potential acute rejection. A few adult studies,…